BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15010695)

  • 1. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
    Cosci F; Bertoli G; Abrams K
    Depress Anxiety; 2013 Dec; 30(12):1217-21. PubMed ID: 23554155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.
    Donny EC; Jones M
    Drug Alcohol Depend; 2009 Sep; 104(1-2):23-33. PubMed ID: 19446968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
    Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
    Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine.
    Johnson MW; Strain EC; Griffiths RR
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):305-15. PubMed ID: 20695686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects.
    Rush CR; Sullivan JT; Griffiths RR
    J Pharmacol Exp Ther; 1995 Apr; 273(1):351-8. PubMed ID: 7714788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual-spatial attention in alcoholics and illicit stimulant abusers: effects of nicotine replacement.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixon SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):97-107. PubMed ID: 15610951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil and nicotine interactions in abstinent smokers.
    Sofuoglu M; Waters AJ; Mooney M
    Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine.
    Miyata H; Hironaka N; Takada K; Miyasato K; Nakamura K; Yanagita T
    Ann N Y Acad Sci; 2008 Oct; 1139():458-65. PubMed ID: 18991893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
    Myers CS; Taylor RC; Moolchan ET; Heishman SJ
    Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone-nicotine interactions in methadone maintenance treatment patients.
    Elkader AK; Brands B; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Jun; 29(3):231-8. PubMed ID: 19440076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.
    Leischow SJ; Valente SN; Hill AL; Otte PS; Aickin M; Holden T; Kligman E; Cook G
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):54-64. PubMed ID: 9234040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixond SJ
    Subst Use Misuse; 2006; 41(3):265-81. PubMed ID: 16467005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.